@thelancetendo.bsky.socialEmerging diagnostic technologies, including targeted genetic testing, #parathyroid autoimmunity assays, and point-of-care calcium monitoring, could enable individualised & real-time management of #hypoparathyroidism thelancet.com/journals/lan...
#PTH #hypocalcaemia #hyperphosphataemia
@eurojendo.bsky.socialRisk of bone overstimulation in long-term PTH(1-34) therapy for hypoparathyroidism by Rebecca Fischler et al
EJE Volume 194, Issue 4, April 2026
Open access 👉 https://doi.org/10.1093/ejendo/lvag053
#endocrinology #hypoparathyroidism #PTH(1-34) #teriparatide
@kireports.bsky.social#Hypomagnesemia in #Hypoparathyroidism, Sensorineural #Deafness, and #Renal #Dysplasia Syndrome Caused by Pathogenic Variants of #GATA3
#VisualAbstract by Husam Alzayer
https://www.kireports.org/article/S2468-0249(26)03310-3/fulltext
@eurojendo.bsky.socialDeterminants of extracellular fluid calcium concentration in patients with chronic #hypoparathyroidism by Arthur Michon-Colin et al
EJE Volume 194, Issue 3, March 2026
👉 https://doi.org/10.1093/ejendo/lvag036
ESE members free via 👉 my.ese-hormones.org
@esendocrinology.bsky.socialAre you a patient with #hypoparathyroidism?
Join our free webinar to hear from clinicians and patients on the impact of hypoparathyroidism, followed by a Q&A.
🌍 Live translation into German, Romanian and Spanish.
Register!👇
@esendocrinology.bsky.socialHave you read our Patient Information Leaflet for Chronic #Hypoparathyroidism in Adults? 📑
15 of our National Partner Societies are helping us create translated editions 🌍
The first of these, in Danish and Portuguese, are now available 👉 https://ow.ly/I32Z50ZQ2Ig
@thelancetendo.bsky.socialEarly findings support the feasibility of generating functional #parathyroid-like cells through biologically informed programming, with in-vitro and in-vivo validation studies underway www.thelancet.com/journals/lan...
#hypoparathyroidism #stemcells #PTH
@thelancetendo.bsky.socialDespite advances in #hypoparathyroidism management, important unmet needs remain, including earlier identification of genetic forms and improved therapies to reduce complications and optimise quality of life (QoL) www.thelancet.com/journals/lan...
#hypocalcaemia #hyperphosphataemia #PTH
@esendocrinology.bsky.socialAre you a patient with #hypoparathyroidism?
Join our webinar to hear from clinicians and patients on the impact of hypoparathyroidism, followed by a Q&A.
🌍 Live translation into German, Romanian and Spanish.
Register for free! 👇
@thelancetendo.bsky.socialAlthough several therapeutic & regenerative approaches remain investigational & require validation in larger long-term studies, #hypoparathyroidism is transitioning from replacement-based management towards biologically targeted & potentially restorative therapies www.thelancet.com/journals/lan... .
@thelancetendo.bsky.socialCalcilytics (eg, encaleret) normalise calcium-sensing receptor (CaSR) hyperactivation in patients with autosomal dominant #hypocalcaemia type 1 and have the potential for broader application in other forms of #hypoparathyroidism thelancet.com/journals/lan...
#hypoparathyroidism
@thelancetendo.bsky.socialFunctional #parathyroid cells derived from pluripotent #stem #cells, including embryonic and induced pluripotent stem cells, represent a potential curative approach for #hypoparathyroidism thelancet.com/journals/lan...
#stemcells
@thelancetendo.bsky.socialChronic hypoparathyroidism is a rare endocrinopathy characterised by hypocalcaemia and hyperphosphataemia due to the absence or severe deficiency of parathyroid hormone (PTH) www.thelancet.com/journals/lan...
#hypoparathyroidism #parathyroid
@thelancetendo.bsky.socialNew—Hypoparathyroidism: translating science from the laboratory to the clinic thelancet.com/journals/lan...
#hypoparathyroidism
